IMCC Key Statistics, Chart & Performance
The current stock price of IMCC is 1.44 USD. In the past month the price decreased by -13.25%. In the past year, price decreased by -40.98%.
IMCC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 49.35 | 1.03T | ||
| JNJ | JOHNSON & JOHNSON | 19.82 | 495.71B | ||
| MRK | MERCK & CO. INC. | 12.6 | 275.48B | ||
| PFE | PFIZER INC | 7.9 | 143.79B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.52 | 113.80B | ||
| ZTS | ZOETIS INC | 20.01 | 55.90B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.8 | 23.24B | ||
| VTRS | VIATRIS INC | 5.41 | 14.51B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.21 | 11.55B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.45B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.72B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 5.05B |
Related stock screener links
About IMCC
Company Profile
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Company Info
IM CANNABIS CORP
Kibbutz Glil Yam
TORONTO ONTARIO IL
CEO: Oren Shuster
Employees: 55
Phone: 14162564202
IM CANNABIS CORP / IMCC FAQ
What does IMCC do?
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Can you provide the latest stock price for IM CANNABIS CORP?
The current stock price of IMCC is 1.44 USD. The price increased by 2.86% in the last trading session.
What is the dividend status of IM CANNABIS CORP?
IMCC does not pay a dividend.
What is the ChartMill technical and fundamental rating of IMCC stock?
IMCC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of IMCC stock?
IM CANNABIS CORP (IMCC) has a market capitalization of 7.56M USD. This makes IMCC a Nano Cap stock.
Can you provide the ownership details for IMCC stock?
You can find the ownership structure of IM CANNABIS CORP (IMCC) on the Ownership tab.
IMCC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IMCC. When comparing the yearly performance of all stocks, IMCC is a bad performer in the overall market: 90.85% of all stocks are doing better.
IMCC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMCC. IMCC has a bad profitability rating. Also its financial health evaluation is rather negative.
IMCC Financial Highlights
Over the last trailing twelve months IMCC reported a non-GAAP Earnings per Share(EPS) of -2.44. The EPS increased by 11.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.43% | ||
| ROE | -88.04% | ||
| Debt/Equity | 2.52 |
IMCC Forecast & Estimates
For the next year, analysts expect an EPS growth of 86.24% and a revenue growth 41.23% for IMCC